Cite
HARVARD Citation
Playford, E. et al. (2020). Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet infectious diseases. 20 (4), pp. 445-454. [Online].